Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar

March 19, 2022 updated by: Mohamed Abd Elnaser Abd Elfattah Ghareeb, Horus University
The purpose of this study will be to compare the effect of hydrocortisone iontophoresis and hydrocortisone phonophoresis on the treatment of surgical scar and overall scar appearance.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Scar contractures develop and extend to the underlying connective tissue and then muscles, leading to reduction in joint range of motion and affecting the day-to-day activities.

Most patients (irrespective of age, gender and ethnicity) believe that even a small improvement in scarring is worthwhile , any research that may help improve scar outcome is meaningful.

The need of this study has developed from the rarity of information about the difference between the effectiveness of iontophoresis and phonophoresis in enhancing the overall appearance of surgical scar.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Damietta, Egypt, 34518
        • Outpatient clinic, Faculty of Physical Therapy, Horus University, Egypt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Both genders
  • same approach of medications
  • scar size varies from 5-15 cm

Exclusion Criteria:

  • have cardiac / pacemakers
  • have significant health problems
  • obese patients (BMI more than 30)
  • uncooperative patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Iontophosresis group
Other: Iontophoresis
Hydrocortisone iontophoresis
Other: traditional PT program
Ultrasound and deep friction massage
Experimental: Phonophoresis group
Other: traditional PT program
Ultrasound and deep friction massage
Other: Phonophoresis
Hydrocortisone Phonophoresis
Experimental: Traditional group
Other: traditional PT program
Ultrasound and deep friction massage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scar pliability
Time Frame: at baseline and after 3 months of intervention
assessment of change in Scar pliability by using tonometer device
at baseline and after 3 months of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Horus University

Investigators

  • Principal Investigator: Mohamed Abdelnaser, Assistant lecturer, Horus University in Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

January 15, 2022

Study Completion (Actual)

February 15, 2022

Study Registration Dates

First Submitted

March 7, 2022

First Submitted That Met QC Criteria

March 19, 2022

First Posted (Actual)

March 24, 2022

Study Record Updates

Last Update Posted (Actual)

March 24, 2022

Last Update Submitted That Met QC Criteria

March 19, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Phd_mghareeb

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scar

Clinical Trials on Iontophoresis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe